These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 26861061)
1. Inhibiting malignant phenotypes of the bladder cancer cells by silencing long noncoding RNA SChLAP1. Zhang J; Shi Z; Nan Y; Li M Int Urol Nephrol; 2016 May; 48(5):711-6. PubMed ID: 26861061 [TBL] [Abstract][Full Text] [Related]
2. Inducing cell growth arrest and apoptosis by silencing long non-coding RNA PCAT-1 in human bladder cancer. Liu L; Liu Y; Zhuang C; Xu W; Fu X; Lv Z; Wu H; Mou L; Zhao G; Cai Z; Huang W Tumour Biol; 2015 Sep; 36(10):7685-9. PubMed ID: 25934337 [TBL] [Abstract][Full Text] [Related]
3. Knockdown of long noncoding RNA FGFR3- AS1 induces cell proliferation inhibition, apoptosis and motility reduction in bladder cancer. Liao X; Chen J; Liu Y; He A; Wu J; Cheng J; Zhang X; Lv Z; Wang F; Mei H Cancer Biomark; 2018 Feb; 21(2):277-285. PubMed ID: 29226855 [TBL] [Abstract][Full Text] [Related]
4. Tetracycline-inducible shRNA targeting antisense long non-coding RNA HIF1A-AS2 represses the malignant phenotypes of bladder cancer. Chen M; Zhuang C; Liu Y; Li J; Dai F; Xia M; Zhan Y; Lin J; Chen Z; He A; Xu W; Zhao G; Guo Y; Cai Z; Huang W Cancer Lett; 2016 Jun; 376(1):155-64. PubMed ID: 27018306 [TBL] [Abstract][Full Text] [Related]
5. Inducing cell proliferation inhibition, apoptosis, and motility reduction by silencing long noncoding ribonucleic acid metastasis-associated lung adenocarcinoma transcript 1 in urothelial carcinoma of the bladder. Han Y; Liu Y; Nie L; Gui Y; Cai Z Urology; 2013 Jan; 81(1):209.e1-7. PubMed ID: 23153939 [TBL] [Abstract][Full Text] [Related]
6. Long noncoding RNA linc00346 promotes the malignant phenotypes of bladder cancer. Ye T; Ding W; Wang N; Huang H; Pan Y; Wei A Biochem Biophys Res Commun; 2017 Sep; 491(1):79-84. PubMed ID: 28705739 [TBL] [Abstract][Full Text] [Related]
7. lncRNA CCAT1 promotes bladder cancer cell proliferation, migration and invasion. Zhang C; Wang W; Lin J; Xiao J; Tian Y Int Braz J Urol; 2019; 45(3):549-559. PubMed ID: 31038865 [TBL] [Abstract][Full Text] [Related]
8. Over-expression of long noncoding RNA BANCR inhibits malignant phenotypes of human bladder cancer. He A; Liu Y; Chen Z; Li J; Chen M; Liu L; Liao X; Lv Z; Zhan Y; Zhuang C; Lin J; Huang W; Mei H J Exp Clin Cancer Res; 2016 Aug; 35(1):125. PubMed ID: 27514530 [TBL] [Abstract][Full Text] [Related]
9. Up-regulation of long non-coding RNA PANDAR is associated with poor prognosis and promotes tumorigenesis in bladder cancer. Zhan Y; Lin J; Liu Y; Chen M; Chen X; Zhuang C; Liu L; Xu W; Chen Z; He A; Zhang Q; Sun X; Zhao G; Huang W J Exp Clin Cancer Res; 2016 May; 35(1):83. PubMed ID: 27206339 [TBL] [Abstract][Full Text] [Related]
10. Effect of siRNA targeting EZH2 on cell viability and apoptosis of bladder cancer T24 cells. Wang HF; Yang H; Hu LB; Lei YH; Qin Y; Li J; Bi CW; Wang JS; Huo Q Genet Mol Res; 2014 Nov; 13(4):9939-50. PubMed ID: 25501205 [TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA CCAT1 promotes human retinoblastoma SO-RB50 and Y79 cells through negative regulation of miR-218-5p. Zhang H; Zhong J; Bian Z; Fang X; Peng Y; Hu Y Biomed Pharmacother; 2017 Mar; 87():683-691. PubMed ID: 28088735 [TBL] [Abstract][Full Text] [Related]
12. Overexpression of CRNDE promotes the progression of bladder cancer. Cheng J; Chen J; Zhang X; Mei H; Wang F; Cai Z Biomed Pharmacother; 2018 Mar; 99():638-644. PubMed ID: 29710461 [TBL] [Abstract][Full Text] [Related]
13. Increased lncRNA ABHD11-AS1 represses the malignant phenotypes of bladder cancer. Chen M; Li J; Zhuang C; Cai Z Oncotarget; 2017 Apr; 8(17):28176-28186. PubMed ID: 28157695 [TBL] [Abstract][Full Text] [Related]
14. Downregulated Long Noncoding RNA PART1 Inhibits Proliferation and Promotes Apoptosis in Bladder Cancer. Hu X; Feng H; Huang H; Gu W; Fang Q; Xie Y; Qin C; Hu X Technol Cancer Res Treat; 2019 Jan; 18():1533033819846638. PubMed ID: 31311442 [TBL] [Abstract][Full Text] [Related]
15. Tetracycline-inducible shRNA targeting long non-coding RNA PVT1 inhibits cell growth and induces apoptosis in bladder cancer cells. Zhuang C; Li J; Liu Y; Chen M; Yuan J; Fu X; Zhan Y; Liu L; Lin J; Zhou Q; Xu W; Zhao G; Cai Z; Huang W Oncotarget; 2015 Dec; 6(38):41194-203. PubMed ID: 26517688 [TBL] [Abstract][Full Text] [Related]
16. Long intergenic non-coding RNA TUG1 is overexpressed in urothelial carcinoma of the bladder. Han Y; Liu Y; Gui Y; Cai Z J Surg Oncol; 2013 Apr; 107(5):555-9. PubMed ID: 22961206 [TBL] [Abstract][Full Text] [Related]
17. Long noncoding RNA in prostate, bladder, and kidney cancer. Martens-Uzunova ES; Böttcher R; Croce CM; Jenster G; Visakorpi T; Calin GA Eur Urol; 2014 Jun; 65(6):1140-51. PubMed ID: 24373479 [TBL] [Abstract][Full Text] [Related]
18. Increased expression of long non-coding RNA CCEPR is associated with poor prognosis and promotes tumorigenesis in urothelial bladder carcinoma. Zhan Y; Li Y; Guan B; Chen X; Chen Z; He A; He S; Gong Y; Peng D; Liu Y; Cai Z; Li X; Zhou L Oncotarget; 2017 Jul; 8(27):44326-44334. PubMed ID: 28574830 [TBL] [Abstract][Full Text] [Related]
19. Increased expression of ZEB1-AS1 correlates with higher histopathological grade and promotes tumorigenesis in bladder cancer. Lin J; Zhan Y; Liu Y; Chen Z; Liang J; Li W; He A; Zhou L; Mei H; Wang F; Huang W Oncotarget; 2017 Apr; 8(15):24202-24212. PubMed ID: 28445936 [TBL] [Abstract][Full Text] [Related]
20. Identification of differentially expressed long noncoding RNAs in bladder cancer. Peter S; Borkowska E; Drayton RM; Rakhit CP; Noon A; Chen W; Catto JW Clin Cancer Res; 2014 Oct; 20(20):5311-21. PubMed ID: 25165097 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]